228 related articles for article (PubMed ID: 16742009)
1. Natalizumab for relapsing multiple sclerosis.
Meyer MA
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742009
[No Abstract] [Full Text] [Related]
2. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Warnke C; Adams O; Kieseier BC
N Engl J Med; 2009 Dec; 361(25):2489; author reply 2489-90. PubMed ID: 20050216
[No Abstract] [Full Text] [Related]
3. Natalizumab for relapsing multiple sclerosis.
Jeffery DR
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742008
[No Abstract] [Full Text] [Related]
4. Natalizumab and progressive multifocal leukoencephalopathy.
Adelman B; Sandrock A; Panzara MA
N Engl J Med; 2005 Jul; 353(4):432-3. PubMed ID: 15947083
[No Abstract] [Full Text] [Related]
5. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
De Gascun CF; Lonergan RM; Hall WW
N Engl J Med; 2009 Dec; 361(25):2488-9; author reply 2489-90. PubMed ID: 20050215
[No Abstract] [Full Text] [Related]
6. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Gorelik L; Goelz S; Sandrock AW
N Engl J Med; 2009 Dec; 361(25):2487-8; author reply 2489-90. PubMed ID: 20018972
[No Abstract] [Full Text] [Related]
7. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.
Schröder A; Lee DH; Hellwig K; Lukas C; Linker RA; Gold R
Arch Neurol; 2010 Nov; 67(11):1391-4. PubMed ID: 20625069
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.
Berger JR; Koralnik IJ
N Engl J Med; 2005 Jul; 353(4):414-6. PubMed ID: 15947082
[No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.
Kleinschmidt-DeMasters BK; Tyler KL
N Engl J Med; 2005 Jul; 353(4):369-74. PubMed ID: 15947079
[TBL] [Abstract][Full Text] [Related]
10. CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus.
Warnke C; Smolianov V; Dehmel T; Andrée M; Hengel H; Zohren F; Arendt G; Wiendl H; Haas R; Hartung HP; Adams O; Kieseier BC
Mult Scler; 2011 Feb; 17(2):151-6. PubMed ID: 21078695
[TBL] [Abstract][Full Text] [Related]
11. Selective treatment of multiple sclerosis.
Ropper AH
N Engl J Med; 2006 Mar; 354(9):965-7. PubMed ID: 16510751
[No Abstract] [Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.
Langer-Gould A; Atlas SW; Green AJ; Bollen AW; Pelletier D
N Engl J Med; 2005 Jul; 353(4):375-81. PubMed ID: 15947078
[TBL] [Abstract][Full Text] [Related]
13. [New drugs; natalizumab].
van Bronswijk H; Dubois EA; van Gerven JM; Cohen AF
Ned Tijdschr Geneeskd; 2008 Mar; 152(9):499-500. PubMed ID: 18389881
[TBL] [Abstract][Full Text] [Related]
14. Natalizumab and immune cells.
McFarland HF; Jacobson S
Arch Neurol; 2006 Oct; 63(10):1366-7. PubMed ID: 17030649
[No Abstract] [Full Text] [Related]
15. Natalizumab for relapsing multiple sclerosis.
Tenser RB
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16738278
[No Abstract] [Full Text] [Related]
16. Rituximab in relapsing-remitting multiple sclerosis.
Schrijver HM
N Engl J Med; 2008 Jun; 358(24):2645; author reply 2646-7. PubMed ID: 18557177
[No Abstract] [Full Text] [Related]
17. Patients at risk.
Drazen JM
N Engl J Med; 2005 Jul; 353(4):417. PubMed ID: 15947081
[No Abstract] [Full Text] [Related]
18. Reply to "'Thinking without thinking' about natalizumab and PML".
Houff S; Berger JR
J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798
[No Abstract] [Full Text] [Related]
19. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Chen Y; Bord E; Tompkins T; Miller J; Tan CS; Kinkel RP; Stein MC; Viscidi RP; Ngo LH; Koralnik IJ
N Engl J Med; 2009 Sep; 361(11):1067-74. PubMed ID: 19741227
[TBL] [Abstract][Full Text] [Related]
20. Reemergence of PML in natalizumab-treated patients--new cases, same concerns.
Major EO
N Engl J Med; 2009 Sep; 361(11):1041-3. PubMed ID: 19741226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
